Danel (Adir Yeoshua) Ltd (TLV:DANE)
Israel
· Delayed Price · Currency is ILS · Price in ILA 45,810
+100 (0.22%)
At close: Dec 4, 2025
Danel (Adir Yeoshua) Revenue
Danel (Adir Yeoshua) had revenue of 739.79M ILS in the quarter ending September 30, 2025, with 4.91% growth. This brings the company's revenue in the last twelve months to 2.87B, up 5.94% year-over-year. In the year 2024, Danel (Adir Yeoshua) had annual revenue of 2.77B with 10.20% growth.
Revenue (ttm)
2.87B
Revenue Growth
+5.94%
P/S Ratio
0.94
Revenue / Employee
668.93K
Employees
4,290
Market Cap
2.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.77B | 256.31M | 10.20% |
| Dec 31, 2023 | 2.51B | 149.89M | 6.34% |
| Dec 31, 2022 | 2.36B | 75.20M | 3.29% |
| Dec 31, 2021 | 2.29B | 303.89M | 15.31% |
| Dec 31, 2020 | 1.98B | 306.79M | 18.28% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Kamada | 578.74M |
| BrainsWay | 162.56M |
| Bait Bakfar | 107.78M |
| SofWave Medical | 255.13M |
| Ilex Medical | 915.05M |
| Novolog (Pharm-Up 1966) | 1.97B |
| InterCure | 243.12M |